Compare AU

Compare DRUG vs. WVOL

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the Edge MSCI World Minimum Volatility (WVOL). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

WVOL

Popularity

Low

Low

Pearlers invested

63

4

Median incremental investment

$967.00

$2,005.19

Median investment frequency

Monthly

Monthly

Median total investment

$1,882.65

$3,626.91

Average age group

26 - 35

> 35


Key Summary

DRUG

WVOL

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

WVOL.AX was created on 2016-10-11 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 91.51m in AUM and 386 holdings. The fund aims to provide investors with the performance of the MSCI World Minimum Volatility (AUD) Index, before fees and expenses.

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

T MOBILE US INC (1.53 %)

JOHNSON & JOHNSON (1.18 %)

BERKSHIRE HATHAWAY INC CLASS B (1.16 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Information Technology (20.14 %)

Health Care (16.42 %)

Consumer Staples (10.94 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

United States (66.44 %)

Japan (10.77 %)

Canada (4.58 %)

Management fee

0.57 %

0.3 %


Key Summary

DRUG

WVOL

Issuer

BetaShares

iShares

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

MSCI World Minimum Volatility (AUD) Index - AUD

Asset class

ETF

ETF

Management fee

0.57 %

0.3 %

Price

$8.15

$42.42

Size

$182.401 million

$89.893 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

1.90 %

2.71 %

Market

ASX

ASX

First listed date

08/08/2016

14/10/2016

Purchase fee

$6.50

$6.50


Community Stats

DRUG

WVOL

Popularity

Low

Low

Pearlers invested

63

4

Median incremental investment

$967.00

$2,005.19

Median investment frequency

Monthly

Monthly

Median total investment

$1,882.65

$3,626.91

Average age group

26 - 35

> 35


Pros and Cons

DRUG

WVOL

Pros

  • Higher exposure to US market

  • Higher price growth

  • Lower management fee

  • Higher distribution yield

Cons

  • Higher management fee

  • Lower distribution yield

  • Lower exposure to US market

  • Lower price growth

DRUG

WVOL

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home